about
Impact of platelet phenotype on myocardial infarction.Novel strategies for assessing platelet reactivity.Platelet function testing as a biomarker for efficacy of antiplatelet drugs.Effect of preanalytical time-delay on platelet function as measured by multiplate, PFA-100 and VerifyNow.Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelor.Application of a strain rate gradient microfluidic device to von Willebrand's disease screening.Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients.
P2860
Q38289218-5013CDDD-B698-41CA-9C37-6ED7DE6AF970Q38780997-5F6F3CB9-EFF6-477E-8380-C4C3F65519EEQ38842001-344D893F-E181-4A97-BBC3-428FB69C7660Q39962890-D26AD0B8-2CAB-47CA-BBA9-F5E5C79015E2Q45276265-82AE3AE4-5DB0-4DE3-A9D3-A11B965BFDA1Q47975691-0069C7CC-5318-4DB9-8F02-406A55326ABAQ49058595-350816E1-BD5A-443A-808E-A85F6A28AC33
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advances in the monitoring of anti-P2Y12 therapy.
@en
type
label
Advances in the monitoring of anti-P2Y12 therapy.
@en
prefLabel
Advances in the monitoring of anti-P2Y12 therapy.
@en
P2860
P1433
P1476
Advances in the monitoring of anti-P2Y12 therapy
@en
P2093
Paul Harrison
P2860
P304
P356
10.3109/09537104.2012.704650
P577
2012-08-23T00:00:00Z